Higher disease activity and systemic inflammation at baseline associated with greater risk of MACE in bDMARD nonusers bu
Tweet Content
Higher disease activity and systemic inflammation at baseline associated with greater risk of MACE in bDMARD nonusers but not in users. bDMARD-specific benefits directly on MACE risk beyond reducing inflammation, Karpouzas et al Abst#0391 #ACR23 @RheumNow https://t.co/lfoccZffTW https://t.co/ASpKYQof1I
Show on Archive Page
On
Display in Search Results
On
PDQ
Off